Literature DB >> 7873193

Hyperoxia amplifies TNF-alpha production in LPS-stimulated human alveolar macrophages.

A R O'Brien-Ladner1, M E Nelson, B D Cowley, K Bailey, L J Wesselius.   

Abstract

Human alveolar macrophages (AM) produce a number of inflammatory mediators including tumor necrosis factor (TNF). TNF-alpha has been implicated in several forms of lung injury including that associated with oxygen toxicity. To investigate whether oxygen could induce or augment the release of TNF from AM, we acquired AM from nonsmoking volunteers and determined TNF release after in vitro hyperoxia. Although TNF release was not induced by oxygen exposure alone, if lipopolysaccharide (LPS) stimulation occurred simultaneously, there was significant augmentation by 60 and 95% oxygen over LPS-stimulated AM exposed to 21% oxygen. This increase was paralleled by a significant increase of interleukin (IL)-1 beta. Dimethylthiourea (DMTU), a hydroxyl radical scavenger, inhibited this release. The increase in TNF extracellular concentrations induced by hyperoxia was not associated with significant increases in intracellular concentration or detectable mRNA over LPS-stimulated AM exposed to 21% oxygen. We hypothesize that hyperoxia exposure may alter the LPS-stimulated AM cytoplasmic milieu, thus further enhancing TNF-alpha production by a post-transcriptional mechanism.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7873193     DOI: 10.1165/ajrcmb.12.3.7873193

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  8 in total

Review 1.  Contribution of neutrophils to acute lung injury.

Authors:  Jochen Grommes; Oliver Soehnlein
Journal:  Mol Med       Date:  2010-10-18       Impact factor: 6.354

2.  Protein expression profile of rat type two alveolar epithelial cells during hyperoxic stress and recovery.

Authors:  Maneesh Bhargava; Sanjoy Dey; Trisha Becker; Michael Steinbach; Baolin Wu; Sang Mee Lee; LeeAnn Higgins; Vipin Kumar; Peter B Bitterman; David H Ingbar; Christine H Wendt
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-09-06       Impact factor: 5.464

3.  Targeted lung expression of interleukin-11 enhances murine tolerance of 100% oxygen and diminishes hyperoxia-induced DNA fragmentation.

Authors:  A B Waxman; O Einarsson; T Seres; R G Knickelbein; J B Warshaw; R Johnston; R J Homer; J A Elias
Journal:  J Clin Invest       Date:  1998-05-01       Impact factor: 14.808

4.  Antioxidants preserve macrophage phagocytosis of Pseudomonas aeruginosa during hyperoxia.

Authors:  Dympna M P Morrow; Tahereh Entezari-Zaher; John Romashko; Ali O Azghani; Mohammad Javdan; Luis Ulloa; Edmund J Miller; Lin L Mantell
Journal:  Free Radic Biol Med       Date:  2007-01-23       Impact factor: 7.376

5.  Attenuation of lipopolysaccharide-induced oxidative stress and apoptosis in fetal pulmonary artery endothelial cells by hypoxia.

Authors:  Venkatesh Sampath; Aaron C Radish; Annie L Eis; Katarzyna Broniowska; Neil Hogg; Girija G Konduri
Journal:  Free Radic Biol Med       Date:  2008-12-24       Impact factor: 7.376

6.  Apolipoprotein E-deficient mice are susceptible to the development of acute lung injury.

Authors:  Cory M Yamashita; Michael B Fessler; Lakshman Vasanthamohan; Joanne Lac; Jennifer Madenspacher; Lynda McCaig; Lijuan Yao; Lefeng Wang; Valeria Puntorieri; Sanjay Mehta; Jim F Lewis; Ruud A W Veldhuizen
Journal:  Respiration       Date:  2014-03-22       Impact factor: 3.580

Review 7.  Impact of Bacterial Toxins in the Lungs.

Authors:  Rudolf Lucas; Yalda Hadizamani; Joyce Gonzales; Boris Gorshkov; Thomas Bodmer; Yves Berthiaume; Ueli Moehrlen; Hartmut Lode; Hanno Huwer; Martina Hudel; Mobarak Abu Mraheil; Haroldo Alfredo Flores Toque; Trinad Chakraborty; Jürg Hamacher
Journal:  Toxins (Basel)       Date:  2020-04-02       Impact factor: 4.546

Review 8.  Animal models of acute lung injury.

Authors:  Gustavo Matute-Bello; Charles W Frevert; Thomas R Martin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-07-11       Impact factor: 5.464

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.